Literature DB >> 9163721

In vivo versus in vitro screening or selection for catalytic activity in enzymes and abzymes.

J Fastrez1.   

Abstract

The recent development of catalytic antibodies and the introduction of new techniques to generate huge libraries of random mutants of existing enzymes have created the need for powerful tools for finding in large populations of cells those producing the catalytically most active proteins. Several approaches have been developed and used to reach this goal. The screening techniques aim at easily detecting the clones producing active enzymes or abzymes; the selection techniques are designed to extract these clones from mixtures. These techniques have been applied both in vivo and in vitro. This review describes the advantages and limitations of the various methods in terms of ease of use, sensitivity, and convenience for handling large libraries. Examples are analyzed and tentative rules proposed. These techniques prove to be quite powerful to study the relationship between structure and function and to alter the properties of enzymes.

Mesh:

Substances:

Year:  1997        PMID: 9163721     DOI: 10.1007/BF02821543

Source DB:  PubMed          Journal:  Mol Biotechnol        ISSN: 1073-6085            Impact factor:   2.695


  129 in total

1.  In vitro selection of RNAs that undergo autolytic cleavage with Pb2+.

Authors:  T Pan; O C Uhlenbeck
Journal:  Biochemistry       Date:  1992-04-28       Impact factor: 3.162

2.  A rapid and effective procedure for screening protease mutants.

Authors:  I Venekei; L Hedstrom; W J Rutter
Journal:  Protein Eng       Date:  1996-01

3.  Development of an efficient method for generating and screening active trypsin and trypsin variants.

Authors:  L B Evnin; C S Craik
Journal:  Ann N Y Acad Sci       Date:  1988       Impact factor: 5.691

4.  Glutathione transferases with novel active sites isolated by phage display from a library of random mutants.

Authors:  M Widersten; B Mannervik
Journal:  J Mol Biol       Date:  1995-07-07       Impact factor: 5.469

5.  A revised strategy for cloning antibody gene fragments in bacteria.

Authors:  B Posner; I Lee; T Itoh; J Pyati; R Graff; G B Thorton; R La Polla; S J Benkovic
Journal:  Gene       Date:  1993-06-15       Impact factor: 3.688

6.  A new TEM beta-lactamase double mutant with broadened specificity reveals substrate-dependent functional interactions.

Authors:  H Viadiu; J Osuna; A L Fink; X Soberón
Journal:  J Biol Chem       Date:  1995-01-13       Impact factor: 5.157

7.  Evolution of antibiotic resistance: several different amino acid substitutions in an active site loop alter the substrate profile of beta-lactamase.

Authors:  T Palzkill; Q Q Le; K V Venkatachalam; M LaRocco; H Ocera
Journal:  Mol Microbiol       Date:  1994-04       Impact factor: 3.501

8.  Isolation of a thermostable enzyme variant by cloning and selection in a thermophile.

Authors:  H Liao; T McKenzie; R Hageman
Journal:  Proc Natl Acad Sci U S A       Date:  1986-02       Impact factor: 11.205

9.  Selection of multiple human immunodeficiency virus type 1 variants that encode viral proteases with decreased sensitivity to an inhibitor of the viral protease.

Authors:  A H Kaplan; S F Michael; R S Wehbie; M F Knigge; D A Paul; L Everitt; D J Kempf; D W Norbeck; J W Erickson; R Swanstrom
Journal:  Proc Natl Acad Sci U S A       Date:  1994-06-07       Impact factor: 11.205

10.  A DNA metalloenzyme with DNA ligase activity.

Authors:  B Cuenoud; J W Szostak
Journal:  Nature       Date:  1995-06-15       Impact factor: 49.962

View more
  2 in total

1.  Directed evolution of an extremely fast phosphotriesterase by in vitro compartmentalization.

Authors:  Andrew D Griffiths; Dan S Tawfik
Journal:  EMBO J       Date:  2003-01-02       Impact factor: 11.598

2.  Investigating the target recognition of DNA cytosine-5 methyltransferase HhaI by library selection using in vitro compartmentalisation.

Authors:  Yin-Fai Lee; Dan S Tawfik; Andrew D Griffiths
Journal:  Nucleic Acids Res       Date:  2002-11-15       Impact factor: 16.971

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.